PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.

Genotype Based Personalized Prescription of Nevirapine

NCT00986063 ·Status: COMPLETED ·Phase: PHASE4

Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)

NCT00615563 ·Status: COMPLETED

A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

NCT07053384 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

NCT00476853 ·Status: COMPLETED ·Phase: PHASE2

Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)

NCT00705419 ·Status: COMPLETED

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

NCT00705926 ·Status: COMPLETED ·Phase: PHASE1

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

NCT00627055 ·Status: COMPLETED ·Phase: PHASE4

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

NCT00144248 ·Status: COMPLETED ·Phase: PHASE4

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

NCT01034917 ·Status: COMPLETED ·Phase: PHASE3

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

NCT01772940 ·Status: COMPLETED ·Phase: PHASE4

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

NCT01968551 ·Status: COMPLETED ·Phase: PHASE3

Effect of Dolutegravir Compared With Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults.

NCT06787976 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients

NCT00274001 ·Status: COMPLETED ·Phase: PHASE4

Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection

NCT03449706 ·Status: RECRUITING

Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

NCT05349838 ·Status: COMPLETED ·Phase: PHASE3

GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults

NCT00257621 ·Status: COMPLETED ·Phase: PHASE2

MK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002)

NCT03552536 ·Status: COMPLETED ·Phase: PHASE1

Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix

NCT07182838 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

NCT00966160 ·Status: COMPLETED ·Phase: PHASE3

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

NCT01266902 ·Status: COMPLETED ·Phase: PHASE3

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

NCT00532168 ·Status: COMPLETED ·Phase: PHASE4

An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy

NCT00193947 ·Status: TERMINATED

Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection

NCT00062660 ·Status: APPROVED_FOR_MARKETING

A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP

NCT00669487 ·Status: COMPLETED ·Phase: PHASE3

Accelerated ART Initiation for PWHIV Who Are Out of Care

NCT06374758 ·Status: RECRUITING ·Phase: PHASE4